|
1
|
Sulaiman MR, Chye FY, Hamid AA and Yatim
AM: The occurrence of aflatoxins in raw shelled peanut samples from
three districts of Perak, Malaysia. Electronic Journal of
Environmental and Food Chemistry. 6:2045–2052. 2007.http://eprints.ums.edu.my/3769/
|
|
2
|
Moradi S, Azari H, Anarkoli IJ,
Qasemi-Panahi B, Elhami S and Forouharmehr A: Effect of aflatoxin
B1 on BRCA1 and BRCA2 genes expression under in vitro cultured cell
line of normal Human Mammary Epithelial Cells (HMEC).
Jan;2015.https://www.researchgate.net/publication/268226306_Effect_of_aflatoxin_B1_on_BRCA1_and_BRCA2_genes_expression_under_in_vitro_cultured_cell_line_of_normal_Human_Mammary_Epithelial_Cells_HMEC
|
|
3
|
Bbosa GS, Kitya D, Lubega A, Ogwal-Okeng
J, Anokbonggo WW and Kyegombe DB: Review of the biological and
health effects of aflatoxins on body organs and body systems.
Aflatoxins - Recent Advances and Future Prospects. Razzaghi-Abyaneh
M: InTech. doi: 10.5772/51201.
|
|
4
|
Mohd-Redzwan S, Jamaluddin R, Abd-Mutalib
MS and Ahmad Z: A mini review on aflatoxin exposure in Malaysia:
Past, present and future. Front Microbiol. 4:3342013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
El-banna AA, Pitt J and Leistner L:
Production of mycotoxins by Penicillium species. Syst Appl
Microbiol. 10:42–46. 1987.doi: 10.1016/S0723-2020(87)80008–5.
View Article : Google Scholar
|
|
6
|
Frisvad JC, Filtenborg O and Thrane U:
Analysis and screening for mycotoxins and other secondary
metabolites in fungal cultures by thin-layer chromatography and
high-performance liquid chromatography. Arch Environ Contam
Toxicol. 18:331–335. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lin L, Zhang J, Wang P, Wang Y and Chen J:
Thin-layer chromatography of mycotoxins and comparison with other
chromatographic methods. J Chromatogr A. 815:3–20. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
van der Gaag B, Spath S, Dietrich H,
Stigter E, Boonzaaijer G, van Osenbruggen T and Koopal K:
Biosensors and multiple mycotoxin analysis. Food Control.
14:251–254. 2003. View Article : Google Scholar
|
|
9
|
Butler WH, Greenblatt M and Lijinsky W:
Carcinogenesis in rats by aflatoxins B1, G1, and B2. Cancer Res.
29:2206–2211. 1969.PubMed/NCBI
|
|
10
|
Creppy EE: Update of survey, regulation
and toxic effects of mycotoxins in Europe. Toxicol Lett. 127:19–28.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ghoshal AK and Farber E: The induction of
liver cancer by dietary deficiency of choline and methionine
without added carcinogens. Carcinogenesis. 5:1367–1370. 1984.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kensler TW, Egner PA, Davidson NE, Roebuck
BD, Pikul A and Groopman JD: Modulation of aflatoxin metabolism,
aflatoxin-N7-guanine formation, and hepatic tumorigenesis in rats
fed ethoxyquin: Role of induction of glutathione S-transferases.
Cancer Res. 46:3924–3931. 1986.PubMed/NCBI
|
|
13
|
Davis ND, Diener UL and Eldridge DW:
Production of aflatoxins B1 and G1 by Aspergillus flavus in a
semisynthetic medium. Appl Microbiol. 14:378–380. 1966.PubMed/NCBI
|
|
14
|
Dorner JW, Cole RJ and Diener UL: The
relationship of Aspergillus flavus and Aspergillus parasiticus with
reference to production of aflatoxins and cyclopiazonic acid.
Mycopathologia. 87:13–15. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Farag RS, Daw ZY and Abo-Raya SH:
Influence of some spice essential oils on Aspergillus parasiticus
growth and production of aflatoxins in a synthetic medium. J Food
Sci. 54:74–76. 1989.doi: 10.1111/j.1365-2621.1989.tb08571.x.
View Article : Google Scholar
|
|
16
|
Mateles RI and Adye JC: Production of
aflatoxins in submerged culture. Appl Microbiol. 13:208–211.
1965.PubMed/NCBI
|
|
17
|
Chu FS: Mycotoxins: food contamination,
mechanism, carcinogenic potential and preventive measures. Mutat
Res. 259:291–306. 1991.doi: 10.1016/0165-1218(91)90124–5.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jelinek CF, Pohland AE and Wood GE:
Worldwide occurrence of mycotoxins in foods and feeds - an update.
J Assoc Off Anal Chem. 72:223–230. 1989.PubMed/NCBI
|
|
19
|
Krogh P: Mycotoxins in food. Academic
Press Ltd.; London: 1987
|
|
20
|
Wang J and Liu XM: Contamination of
aflatoxins in different kinds of foods in China. Biomed Environ
Sci. 20:483–487. 2007.PubMed/NCBI
|
|
21
|
Rustom IY: Aflatoxin in food and feed:
Occurrence, legislation and inactivation by physical methods. Food
Chem. 59:57–67. 1997. View Article : Google Scholar
|
|
22
|
Tabata S, Kamimura H, Ibe A, Hashimoto H,
Iida M, Tamura Y and Nishima T: Aflatoxin contamination in foods
and foodstuffs in Tokyo: 1986–1990. J AOAC Int. 76:32–35.
1993.PubMed/NCBI
|
|
23
|
Lane KS: Aflatoxin, tobacco, ammonia and
the p53 tumor-suppressor gene: Cancer's missing link? MedGenMed.
1:E101999.
|
|
24
|
Hill RA, Blankenship PD, Cole RJ and
Sanders TH: Effects of soil moisture and temperature on preharvest
invasion of peanuts by the Aspergillus flavus group and subsequent
aflatoxin development. Appl Environ Microbiol. 45:628–633.
1983.PubMed/NCBI
|
|
25
|
Desjardins AE: Fusarium mycotoxins:
chemistry, genetics, and biologyAmerican Phytopathological Society.
APS Press; St. Paul, MN: 2006
|
|
26
|
Placinta C, D'mello J and Macdonald A: A
review of worldwide contamination of cereal grains and animal feed
with Fusarium mycotoxins. Anim Feed Sci Technol. 78:21–37. 1999.
View Article : Google Scholar
|
|
27
|
Richard JL: Some major mycotoxins and
their mycotoxicoses - an overview. Int J Food Microbiol. 119:3–10.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gelderblom WC, Jaskiewicz K, Marasas WF,
Thiel PG, Horak RM, Vleggaar R and Kriek NP: Fumonisins - novel
mycotoxins with cancer-promoting activity produced by Fusarium
moniliforme. Appl Environ Microbiol. 54:1806–1811. 1988.PubMed/NCBI
|
|
29
|
Sydenham EW, Shephard GS, Thiel PG,
Stockenström S, Snijman PW and Van Schalkwyk DJ: Liquid
chromatographic determination of fumonisins B1, B2, and B3 in corn:
AOAC-IUPAC Collaborative Study. J AOAC Int. 79:688–696.
1996.PubMed/NCBI
|
|
30
|
Gimeno A: Thin layer chromatographic
determination of aflatoxins, ochratoxins, sterigmatocystin,
zearalenone, citrinin, T-2 toxin, diacetoxyscirpenol, penicillic
acid, patulin, and penitrem A. J Assoc Off Anal Chem. 62:579–585.
1979.PubMed/NCBI
|
|
31
|
Petzinger E and Weidenbach A: Mycotoxins
in the food chain: The role of ochratoxins. Livest Prod Sci.
76:245–250. 2002. View Article : Google Scholar
|
|
32
|
Trenk HL, Butz ME and Chu FS: Production
of ochratoxins in different cereal products by Aspergillus
ochraceus. Appl Microbiol. 21:1032–1035. 1971.PubMed/NCBI
|
|
33
|
Cavin C, Delatour T, Marin-Kuan M,
Holzhäuser D, Higgins L, Bezençon C, Guignard G, Junod S,
Richoz-Payot J, Gremaud E, et al: Reduction in antioxidant defenses
may contribute to Ochratoxin A toxicity and carcinogenicity.
Toxicol Sci. 96:30–39. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fink-Gremmels J, Jahn A and Blom MJ:
Toxicity and metabolism of Ochratoxin A. Nat Toxins. 3:214–220,
discussion 221. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Rahimtula AD, Béréziat J-C,
Bussacchini-Griot V and Bartsch H: Lipid peroxidation as a possible
cause of Ochratoxin A toxicity. Biochem Pharmacol. 37:4469–4477.
1988. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Battilani P, Giorni P and Pietri A:
Epidemiology of toxin-producing fungi and Ochratoxin A occurrence
in grapeEpidemiology of Mycotoxin Producing Fungi. Springer; pp.
715–722. 2003, doi: 10.1007/978-94-017-1452-5_6. View Article : Google Scholar
|
|
37
|
Czerwiecki L, Czajkowska D and
Witkowska-Gwiazdowska A: On Ochratoxin A and fungal flora in Polish
cereals from conventional and ecological farms. Part 2: Occurrence
of Ochratoxin A and fungi in cereals in 1998. Food Addit Contam.
19:1051–1057. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Duarte SC, Pena A and Lino CM: A review on
Ochratoxin A occurrence and effects of processing of cereal and
cereal derived food products. Food Microbiol. 27:187–198. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Shotwell OL, Hesseltine CW and Goulden ML:
Ochratoxin A: Occurrence as natural contaminant of a corn sample.
Appl Microbiol. 17:765–766. 1969.PubMed/NCBI
|
|
40
|
López-García R: Mycotoxin management: an
international challengeEnsuring Global Food Safety: Exploring
Global Harmonization. Boisrobert C, et al: Elsevier; pp. 209–216.
2009
|
|
41
|
Bennett JW and Klich M: Mycotoxins. Clin
Microbiol Rev. 16:497–516. 2003.doi: 10.1128/CMR.16.3.497-516.2003.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Squire RA: Ranking animal carcinogens: A
proposed regulatory approach. Science. 214:877–880. 1981.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Goto T, Wicklow DT and Ito Y: Aflatoxin
and cyclopiazonic acid production by a sclerotium-producing
Aspergillus tamarii strain. Appl Environ Microbiol. 62:4036–4038.
1996.PubMed/NCBI
|
|
44
|
Klich MA, Mullaney EJ, Daly CB and Cary
JW: Molecular and physiological aspects of aflatoxin and
sterigmatocystin biosynthesis by Aspergillus tamarii and A.
ochraceoroseus. Appl Microbiol Biotechnol. 53:605–609. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Peterson SW, Ito Y, Horn BW and Goto T:
Aspergillus bombycis, a new aflatoxigenic species and genetic
variation in its sibling species, A. nomius. Mycologia. 93:689–703.
2001. View Article : Google Scholar
|
|
46
|
Heathcote JG and Hibbert J: Aflatoxins:
Chemical and Biological aspects. Elsevier Scientific Publishing
Co.; Amsterdam: 1978
|
|
47
|
Bennett JW, Chang PK and Bhatnagar D: One
gene to whole pathway: The role of norsolorinic acid in aflatoxin
research. Adv Appl Microbiol. 45:1–15. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Cleveland TE and Bhatnagar D: Molecular
strategies for reducing aflatoxin levels in crops before
harvestMolecular Approaches to Improving Food Quality and Safety.
Springer; pp. 205–228. 1992, doi: 10.1007/978-1-4684-8070-2_9.
View Article : Google Scholar
|
|
49
|
Hicks JK, Shimizu K and Keller NP:
Genetics and biosynthesis of aflatoxins and sterigmatocystin. The
Mycota XIAgricultural Applications. Kempken F: Springer-Verlag;
Berlin: pp. 55–69. 2002, View Article : Google Scholar
|
|
50
|
Payne GA and Brown MP: Genetics and
physiology of aflatoxin biosynthesis. Annu Rev Phytopathol.
36:329–362. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Townsend C: Progress toward a biosynthetic
rationale of the aflatoxin pathway. Pure Appl Chem. 58:227–238.
1986. View Article : Google Scholar
|
|
52
|
Trail F, Mahanti N and Linz J: Molecular
biology of aflatoxin biosynthesis. Microbiology. 141:755–765. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Hackbart H, Prietto L, Primel EG,
Garda-Buffon J and Badiale-Furlong E: Simultaneous extraction and
detection of Ochratoxin A and citrinin in rice. J Braz Chem Soc.
23:103–109. 2012. View Article : Google Scholar
|
|
54
|
Aleo MD, Wyatt RD and Schnellmann RG: The
role of altered mitochondrial function in citrinin-induced toxicity
to rat renal proximal tubule suspensions. Toxicol Appl Pharmacol.
109:455–463. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Manabe M: Fermented foods and mycotoxins.
J Jpn Assoc Mycotoxicol. 51:25–29. 2001. View Article : Google Scholar
|
|
56
|
Carlton WW and Tuite J: Metabolites of P.
viridicatum toxicologyMycotoxins in Human and Animal Health.
Mehlman MA: Pathotox Publications, Inc.; Park Forest South, IL: pp.
525–555. 1977
|
|
57
|
Saito M, Enomoto M, Tatsuno T and Uraguchi
K: Yellowed Rice Toxins: Luteoskyrin and Related Compounds,
Chlorine-Containing Compounds, and Citrinin. Ajl, Samuel J Microb
Toxins. 1971.
|
|
58
|
Richard JL: Mycotoxins - an overview.
Romer Labs' Guide To Mycotoxins. 2012.
|
|
59
|
Bennett J and Bentley R: Pride and
prejudice: The story of ergot. Perspect Biol Med. 42:333–355. 1999.
View Article : Google Scholar
|
|
60
|
Sweeney MJ and Dobson AD: Molecular
biology of mycotoxin biosynthesis. FEMS Microbiol Lett.
175:149–163. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Lia Y, Lou L, Cerny RL, Butchko RA,
Proctor RH, Shen Y and Du L: Tricarballylic ester formation during
biosynthesis of fumonisin mycotoxins in Fusarium verticillioides.
Mycology. 4:179–186. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Van der Merwe KJ, Steyn PS, Fourie L,
Scott DB and Theron JJ: Ochratoxin A, a toxic metabolite produced
by Aspergillus ochraceus Wilh. Nature. 205:1112–1113. 1965.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Huang B, Tao W, Shi J, Tang L and Jin J:
Determination of Ochratoxin A by polyclonal antibodies based
sensitive time-resolved fluoroimmunoassay. Arch Toxicol.
80:481–485. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Ciegler A, Detroy RW and Lillehoj EB:
Patulin, penicillic acid, and other carcinogenic lactonesMicrobial
Toxins. Ciegler A, Kadis S and Ajl SJ: 6. Academic Press; New York:
pp. 409–434. 1971
|
|
65
|
Sekiguchi J and Gaucher GM: Identification
of phyllostine as an intermediate of the patulin pathway in
Penicillium urticae. Biochemistry. 17:1785–1791. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Cole RJ and Cox RH: The
trichothecenesHandbook of Toxic Fungal Metabolites. Academic Press;
New York: pp. 152–263. 1981, View Article : Google Scholar
|
|
67
|
Scott PM: The natural occurrence of
trichothecenesTrichothecene mycotoxicosis: Pathophysiologic
effects. Beasley VR: 1. CRC Press; Boca Raton, FL: pp. 1–26.
1989
|
|
68
|
Ueno Y: TrichothecenesChemical, Biological
and Toxicological Aspects. Elsevier; Amsterdam: 1983
|
|
69
|
Marasas WFO, Nelson PE and Toussoun TA:
Toxigenic Fusarium speciesIdentity and mycotoxicology. University
Park: Pennsylvania State University Press; 1984
|
|
70
|
Hinkley SF and Jarvis BB: 15
Chromatographic method for Stachybotrys toxinsMycotoxin Protocols.
157. Humana Press; pp. 173–194. 2001, View Article : Google Scholar
|
|
71
|
Urry W, Wehrmeister H, Hodge E and Hidy P:
The structure of zearalenone. Tetrahedron Lett. 7:3109–3114. 1966.
View Article : Google Scholar
|
|
72
|
Cousin MA, Riley RT and Pestka JJ:
Foodborne Mycotoxins: Chemistry, Biology, Ecology, and Toxicology.
Caister Academic Press; Norfolk: 2005
|
|
73
|
Bullerman LB and Bianchini A: Stability of
mycotoxins during food processing. Int J Food Microbiol.
119:140–146. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Visconti A and Pascale M: REVIEW: An
overview on Fusarium mycotoxins in the durum wheat pasta production
chain. Cereal Chem. 87:21–27. 2010. View Article : Google Scholar
|
|
75
|
Kabak B: The fate of mycotoxins during
thermal food processing. J Sci Food Agric. 89:549–554. 2009.
View Article : Google Scholar
|
|
76
|
Scott P: Effects of food processing on
mycotoxins. J Food Prot. 47:489–499. 1984. View Article : Google Scholar
|
|
77
|
Doyle M, Applebaum R, Brackett R and Marth
E: Physical, chemical and biological degradation of mycotoxins in
foods and agricultural commodities. J Food Prot. 45:964–971. 1982.
View Article : Google Scholar
|
|
78
|
Lauren DR and Smith WA: Stability of the
fusarium mycotoxins nivalenol, deoxynivalenol and zearalenone in
ground maize under typical cooking environments. Food Addit Contam.
18:1011–1016. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Gund P: Guanidine, trimethylenemethane,
and Y-delocalization. Can acyclic compounds have aromatic
stability? J Chem Educ. 49:1001972.
|
|
80
|
Silverstein RM and Bassler GC:
Spectrometric identification of organic compounds. J Chem Educ.
39:5461962. View Article : Google Scholar
|
|
81
|
Abbas HK: Aflatoxin and Food Safety. CRC
Press; 2005, doi: 10.1201/9781420028171. View Article : Google Scholar
|
|
82
|
Jarvis BB and Miller JD: Mycotoxins as
harmful indoor air contaminants. Appl Microbiol Biotechnol.
66:367–372. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Serra R, Braga A and Venâncio A:
Mycotoxin-producing and other fungi isolated from grapes for wine
production, with particular emphasis on Ochratoxin A. Res
Microbiol. 156:515–521. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Agag B: Mycotoxins in foods and feeds:
1-aflatoxins. Assiut Univ Bull Environ Res. 7:173–205. 2004.
|
|
85
|
Eaton DL and Groopman JD: Toxicology of
Aflatoxins: Human Health, Veterinary, and Agricultural
Significance. Elsevier; 2013
|
|
86
|
He XY, Tang L, Wang SL, Cai QS, Wang JS
and Hong JY: Efficient activation of aflatoxin B1 by cytochrome
P450 2A13, an enzyme predominantly expressed in human respiratory
tract. Int J Cancer. 118:2665–2671. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Baertschi SW, Raney KD, Stone MP and
Harris TM: Preparation of the 8, 9-epoxide of the mycotoxin
aflatoxin B1: The ultimate carcinogenic species. J Am Chem Soc.
110:7929–7931. 1988. View Article : Google Scholar
|
|
88
|
Yates MS, Kwak M-K, Egner PA, Groopman JD,
Bodreddigari S, Sutter TR, Baumgartner KJ, Roebuck BD, Liby KT,
Yore MM, et al: Potent protection against aflatoxin-induced
tumorigenesis through induction of Nrf2-regulated pathways by the
triterpenoid
1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole. Cancer
Res. 66:2488–2494. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Boorman GA, McDonald MR, Imoto S and
Persing R: Renal lesions induced by Ochratoxin A exposure in the
F344 rat. Toxicol Pathol. 20:236–245. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Chu Y-M, Jeon J-J, Yea S-J, Kim Y-H, Yun
S-H, Lee Y-W and Kim KH: Double-stranded RNA mycovirus from
Fusarium graminearum. Appl Environ Microbiol. 68:2529–2534. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Kuiper-Goodman T and Scott PM: Risk
assessment of the mycotoxin Ochratoxin A. Biomed Environ Sci.
2:179–248. 1989.PubMed/NCBI
|
|
92
|
Bunge I, Heller K and Röschenthaler R:
Isolation and purification of Ochratoxin A. Zeitschrift
fürLebensmitteluntersuchung und-Forschung. 168:457–458. 1979.doi:
10.1007/BF01479260. View Article : Google Scholar
|
|
93
|
Marquardt RR and Frohlich AA: A review of
recent advances in understanding ochratoxicosis. J Anim Sci.
70:3968–3988. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Meisner H and Meisner P: Ochratoxin A, an
in vivo inhibitor of renal phosphoenolpyruvate carboxykinase. Arch
Biochem Biophys. 208:146–153. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Rocha O, Ansari K and Doohan FM: Effects
of trichothecene mycotoxins on eukaryotic cells: A review. Food
Addit Contam. 22:369–378. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Desmond OJ, Manners JM, Stephens AE,
Maclean DJ, Schenk PM, Gardiner DM, Munn AL and Kazan K: The
Fusarium mycotoxin deoxynivalenol elicits hydrogen peroxide
production, programmed cell death and defence responses in wheat.
Mol Plant Pathol. 9:435–445. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Pestka JJ: Deoxynivalenol-induced IgA
production and IgA nephropathy-aberrant mucosal immune response
with systemic repercussions. Toxicol Lett. 140–141, 287–295.
2003.
|
|
98
|
Bunner DL and Morris ER: Alteration of
multiple cell membrane functions in L-6 myoblasts by T-2 toxin: An
important mechanism of action. Toxicol Appl Pharmacol. 92:113–121.
1988. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Diamond M, Reape TJ, Rocha O, Doyle SM,
Kacprzyk J, Doohan FM and McCabe PF: The fusarium mycotoxin
deoxynivalenol can inhibit plant apoptosis-like programmed cell
death. PLoS One. 8:e695422013. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Hansen B: Inhibition of protein synthesis
by trichothecenesMycotoxins in Human and Animal Health. Meky FA,
Hardie LJ, Evans SW and Wild CP: Pathotox Publications; Park Forest
South, IL: pp. 263–273. 2001
|
|
101
|
Thompson WL and Wannemacher RW Jr:
Detection and quantitation of T-2 mycotoxin with a simplified
protein synthesis inhibition assay. Appl Environ Microbiol.
48:1176–1180. 1984.PubMed/NCBI
|
|
102
|
Wannemacher RW, Wiener SL, Sidell FR,
Takafuji ET and Franz DR: Trichothecene mycotoxins. Medical Aspects
of Chemical and Biological Warfare. 655–676. 1997.
|
|
103
|
Yang G-H, Jarvis BB, Chung Y-J and Pestka
JJ: Apoptosis induction by the satratoxins and other trichothecene
mycotoxins: Relationship to ERK p38 MAPK, and SAPK/JNK activation.
Toxicol Appl Pharmacol. 164:149–160. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Zhou H-R, Islam Z and Pestka JJ: Rapid,
sequential activation of mitogen-activated protein kinases and
transcription factors precedes proinflammatory cytokine mRNA
expression in spleens of mice exposed to the trichothecene
vomitoxin. Toxicol Sci. 72:130–142. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Sansing GA, Lillehoj EB, Detroy RW and
Miller MA: Synergistic toxic effects of citrinin, Ochratoxin A and
penicillic acid in mice. Toxicon. 14:213–220. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Wichmann G, Herbarth O and Lehmann I: The
mycotoxins citrinin, gliotoxin, and patulin affect interferon-γ
rather than interleukin-4 production in human blood cells. Environ
Toxicol. 17:211–218. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Dönmez-Altuntas H, Dumlupinar G, Imamoglu
N, Hamurcu Z and Liman BC: Effects of the mycotoxin citrinin on
micronucleus formation in a cytokinesis-block genotoxicity assay in
cultured human lymphocytes. J Appl Toxicol. 27:337–341. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Flajs D and Peraica M: Toxicological
properties of citrinin. Arh Hig Rada Toksikol. 60:457–464. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Bhat R, Rai RV and Karim AA: Mycotoxins in
food and feed: present status and future concerns. Compr Rev Food
Sci Food Saf. 9:57–81. 2010.doi: 10.1111/j.1541-4337.2009.00094.x.
View Article : Google Scholar
|
|
110
|
Matossian MK: Mold poisoning: An
unrecognized English health problem, 1550–1800. Med Hist. 25:73–84.
1981. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Matossian MK: Poisons of the Past: Molds,
Epidemics, and History. Yale University Press; New Haven and
London: 1989, Arch Nat Hist. 18. pp. 145Available online: Jul 2010.
http://dx.doi.org/10.3366/anh.1991.18.1.145
|
|
112
|
Binder EM: Managing the risk of mycotoxins
in modern feed production. Anim Feed Sci Technol. 133:149–166.
2007. View Article : Google Scholar
|
|
113
|
Lorenz K and Hoseney RC: Ergot on cereal
grains. Crit Rev Food Sci Nutr. 11:311–354. 1979. View Article : Google Scholar
|
|
114
|
Riddle JM: Eve's Herbs: A History of
Contraception and Abortion in the West. Harvard University Press;
1999
|
|
115
|
Caballero-Granado FJ, Viciana P, Cordero
E, Gómez-Vera MJ, del Nozal M and López-Cortés LF: Ergotism related
to concurrent administration of ergotamine tartrate and ritonavir
in an AIDS patient. Antimicrob Agents Chemother.
41:12071997.PubMed/NCBI
|
|
116
|
Alberts JF, Gelderblom WC, Thiel PG,
Marasas WF, Van Schalkwyk DJ and Behrend Y: Effects of temperature
and incubation period on production of fumonisin B1 by Fusarium
moniliforme. Appl Environ Microbiol. 56:1729–1733. 1990.PubMed/NCBI
|
|
117
|
Gelderblom WC, Smuts CM, Abel S, Snyman
SD, Cawood ME, van der Westhuizen L and Swanevelder S: Effect of
fumonisin B1 on protein and lipid synthesis in primary rat
hepatocytes. Food Chem Toxicol. 34:361–369. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Pozzi CR, Corrêa B, Xavier JG, Direito GM,
Orsi RB and Matarazzo SV: Effects of prolonged oral administration
of fumonisin B1 and aflatoxin B1 in rats. Mycopathologia.
151:21–27. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Sydenham EW, Shephard GS, Thiel PG,
Marasas WF and Stockenstrom S: Fumonisin contamination of
commercial corn-based human foodstuffs. J Agric Food Chem.
39:2014–2018. 1991. View Article : Google Scholar
|
|
120
|
Kouadio JH, Mobio TA, Baudrimont I, Moukha
S, Dano SD and Creppy EE: Comparative study of cytotoxicity and
oxidative stress induced by deoxynivalenol, zearalenone or
fumonisin B1 in human intestinal cell line Caco-2. Toxicology.
213:56–65. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Tolleson WH, Melchior WB Jr, Morris SM,
McGarrity LJ, Domon OE, Muskhelishvili L, James SJ and Howard PC:
Apoptotic and anti-proliferative effects of fumonisin B1 in human
keratinocytes, fibroblasts, esophageal epithelial cells and
hepatoma cells. Carcinogenesis. 17:239–249. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Hendricks KA, Simpson JS and Larsen RD:
Neural tube defects along the Texas-Mexico border, 1993–1995. Am J
Epidemiol. 149:1119–1127. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Missmer S, Hendricks K, Suarez L, Larsen R
and Rothman I: Fumonisins and neural tube defects. Epidemiology.
11:183–184. 2000.
|
|
124
|
Rheeder JP, Marasas WF and Vismer HF:
Production of fumonisin analogs by Fusarium species. Appl Environ
Microbiol. 68:2101–2105. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Trucksess MW and Tang Y: Solid-phase
extraction method for patulin in apple juice and unfiltered apple
juice. J AOAC Int. 82:1109–1113. 1999.PubMed/NCBI
|
|
126
|
Stafford ME and McLaughlin CS:
Trichodermin, a possible inhibitor of the termination process of
protein synthesis. J Cell Physiol. 82:121–128. 1973. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Wei C-M, Campbell IM, McLaughlin CS and
Vaughan MH: Letter: Binding of trichodermin to mammalian ribosomes
and its inhibition by other 12,13-epoxytrichothecenes. Mol Cell
Biochem. 3:215–219. 1974. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Bennett JW and Klich M: Mycotoxins. Clin
Microbiol Rev. 16:497–516. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Rotter BA: Invited review: Toxicology of
deoxynivalenol (vomitoxin). J Toxicol Environ Health A. 48:1–34.
1996. View Article : Google Scholar
|
|
130
|
Islam Z, Gray JS and Pestka JJ: p38
Mitogen-activated protein kinase mediates IL-8 induction by the
ribotoxin deoxynivalenol in human monocytes. Toxicol Appl
Pharmacol. 213:235–244. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Zain ME: Impact of mycotoxins on humans
and animals. J Saudi Chem Soc. 15:129–144. 2011. View Article : Google Scholar
|
|
132
|
Ueno Y, Umemori K, Niimi E, Tanuma S,
Nagata S, Sugamata M, Ihara T, Sekijima M, Kawai K, Ueno I, et al:
Induction of apoptosis by T-2 toxin and other natural toxins in
HL-60 human promyelotic leukemia cells. Nat Toxins. 3:129–137.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Yarom R, More R, Eldor A and Yagen B: The
effect of T-2 toxin on human platelets. Toxicol Appl Pharmacol.
73:210–217. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Sudakin DL: Trichothecenes in the
environment: Relevance to human health. Toxicol Lett. 143:97–107.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Lautraite S, Parent-Massin D, Rio B and
Hoellinger H: Comparison of toxicity induced by T-2 toxin on human
and rat granulo-monocytic progenitors with an in vitro model. Hum
Exp Toxicol. 14:672–678. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Kuhn DM and Ghannoum MA: Indoor mold,
toxigenic fungi, and Stachybotrys chartarum: Infectious disease
perspective. Clin Microbiol Rev. 16:144–172. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Kuiper-Goodman T, Scott PM and Watanabe H:
Risk assessment of the mycotoxin zearalenone. Regul Toxicol
Pharmacol. 7:253–306. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Utian WH: Comparative trial of P1496, a
new non-steroidal oestrogen analogue. BMJ. 1:579–581. 1973.
View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Shier WT, Shier AC, Xie W and Mirocha CJ:
Structure-activity relationships for human estrogenic activity in
zearalenone mycotoxins. Toxicon. 39:1435–1438. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Kanora A and Maes D: The role of
mycotoxins in pig reproduction: a review. Vet Med Czech.
54:565–576. 2009.
|
|
141
|
Ueno Y and Kubota K: DNA-attacking ability
of carcinogenic mycotoxins in recombination-deficient mutant cells
of Bacillus subtilis. Cancer Res. 36:445–451. 1976.PubMed/NCBI
|
|
142
|
Uraguchi K, Saito M, Noguchi Y, Takahashi
K, Enomoto M and Tatsuno T: Chronic toxicity and carcinogenicity in
mice of the purified mycotoxins, luteoskyrin and cyclochlorotine.
Food Cosmet Toxicol. 10:193–207. 1972. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Voss KA, Howard PC, Riley RT, Sharma RP,
Bucci TJ and Lorentzen RJ: Carcinogenicity and mechanism of action
of fumonisin B1: A mycotoxin produced by Fusarium moniliforme (= F.
verticillioides). Cancer Detect Prev. 26:1–9. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Mori H, Kawai K, Ohbayashi F, Kuniyasu T,
Yamazaki M, Hamasaki T and Williams GM: Genotoxicity of a variety
of mycotoxins in the hepatocyte primary culture/DNA repair test
using rat and mouse hepatocytes. Cancer Res. 44:2918–2923.
1984.PubMed/NCBI
|
|
145
|
Newberne PM: Mycotoxins: Toxicity,
carcinogenicity, and the influence of various nutritional
conditions. Environ Health Perspect. 9:1–32. 1974. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Gradelet S, Astorg P, Le B, on A-M, Bergès
R and Suschetet M: Modulation of aflatoxin B1 carcinogenicity,
genotoxicity and metabolism in rat liver by dietary carotenoids:
Evidence for a protective effect of CYP1A inducers. Cancer Lett.
114:221–223. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Massey TE, Stewart RK, Daniels JM and Liu
L: Biochemical and molecular aspects of mammalian susceptibility to
aflatoxin B1 carcinogenicity. Proc Soc Exp Biol Med. 208:213–227.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Iyer RS, Coles BF, Raney KD, Thier R,
Guengerich FP and Harris TM: DNA adduction by the potent carcinogen
aflatoxin B1: Mechanistic studies. J Am Chem Soc. 116:1603–1609.
1994. View Article : Google Scholar
|
|
149
|
Johnson WW and Guengerich FP: Reaction of
aflatoxin B1 exo-8,9-epoxide with DNA: Kinetic analysis of covalent
binding and DNA-induced hydrolysis. Proc Natl Acad Sci USA.
94:6121–6125. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Wilson SC, Howard PW, Forrow SM, Hartley
JA, Adams LJ, Jenkins TC, Kelland LR and Thurston DE: Design,
synthesis, and evaluation of a novel sequence-selective
epoxide-containing DNA cross-linking agent based on the
pyrrolo[2,1-c][1,4]benzodiazepine system. J Med Chem. 42:4028–4041.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Hollstein M, Sidransky D, Vogelstein B and
Harris CC: p53 mutations in human cancers. Science. 253:49–53.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Chen J, Goetchius MP, Campbell TC and
Combs GF Jr.: Effects of dietary selenium and vitamin E on hepatic
mixed-function oxidase activities and in vivo covalent binding of
aflatoxin B1 in rats. J Nutr. 112:324–331. 1982.PubMed/NCBI
|
|
153
|
Peers FG and Linsell CA: Dietary
aflatoxins and liver cancer - a population based study in Kenya. Br
J Cancer. 27:473–484. 1973. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Aguilar F, Hussain SP and Cerutti P:
Aflatoxin B1 induces the transversion of G->T in codon 249 of
the p53 tumor suppressor gene in human hepatocytes. Proc Natl Acad
Sci USA. 90:8586–8590. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Van Rensburg SJ, Cook-Mozaffari P, Van
Schalkwyk DJ, van der Watt JJ, Vincent TJ and Purchase IF:
Hepatocellular carcinoma and dietary aflatoxin in Mozambique and
Transkei. Br J Cancer. 51:713–726. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Sun G, Wang S, Hu X, Su J, Huang T, Yu J,
Tang L, Gao W and Wang JS: Fumonisin B1 contamination of home-grown
corn in high-risk areas for esophageal and liver cancer in China.
Food Addit Contam. 24:181–185. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Kelly JD, Eaton DL, Guengerich FP and
Coulombe RA Jr.: Aflatoxin B1 activation in human lung. Toxicol
Appl Pharmacol. 144:88–95. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Divine KK, Gilliland FD, Crowell RE,
Stidley CA, Bocklage TJ, Cook DL and Belinsky SA: The XRCC1 399
glutamine allele is a risk factor for adenocarcinoma of the lung.
Mutat Res. 461:273–278. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Dvorackova I, Stora C and Ayraud N:
Evidence of aflatoxin B1 in two cases of lung cancer in man. J
Cancer Res Clin Oncol. 100:221–224. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Zhang X, Miao X, Liang G, Hao B, Wang Y,
Tan W, Li Y, Guo Y, He F, Wei Q, et al: Polymorphisms in DNA base
excision repair genes ADPRT and XRCC1 and risk of lung cancer.
Cancer Res. 65:722–726. 2005.PubMed/NCBI
|
|
161
|
Ketterer B, Harris JM, Talaska G, Meyer
DJ, Pemble SE, Taylor JB, Lang NP and Kadlubar FF: The human
glutathione S-transferase supergene family, its polymorphism, and
its effects on susceptibility to lung cancer. Environ Health
Perspect. 98:87–94. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Marin-Kuan M, Nestler S, Verguet C,
Bezençon C, Piguet D, Mansourian R, Holzwarth J, Grigorov M,
Delatour T, Mantle P, et al: A toxicogenomics approach to identify
new plausible epigenetic mechanisms of Ochratoxin A carcinogenicity
in rat. Toxicol Sci. 89:120–134. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Marin-Kuan M, Cavin C, Delatour T and
Schilter B: Ochratoxin A carcinogenicity involves a complex network
of epigenetic mechanisms. Toxicon. 52:195–202. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Dörrenhaus A, Flieger A, Golka K, Schulze
H, Albrecht M, Degen GH and Föllmann W: Induction of unscheduled
DNA synthesis in primary human urothelial cells by the mycotoxin
Ochratoxin A. Toxicol Sci. 53:271–277. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Boesch-Saadatmandi C, Loboda A, Jozkowicz
A, Huebbe P, Blank R, Wolffram S, Dulak J and Rimbach G: Effect of
Ochratoxin A on redox-regulated transcription factors, antioxidant
enzymes and glutathione-S-transferase in cultured kidney tubulus
cells. Food Chem Toxicol. 46:2665–2671. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Pfohl-Leszkowicz A and Manderville RA: An
update on direct genotoxicity as a molecular mechanism of
Ochratoxin A carcinogenicity. Chem Res Toxicol. 25:252–262. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Adler M, Müller K, Rached E, Dekant W and
Mally A: Modulation of key regulators of mitosis linked to
chromosomal instability is an early event in Ochratoxin A
carcinogenicity. Carcinogenesis. 30:711–719. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
González-Salgado A, Patiño B, Vázquez C
and González-Jaén MT: Discrimination of Aspergillus niger and other
Aspergillus species belonging to section Nigri by PCR assays. FEMS
Microbiol Lett. 245:353–361. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Lioi MB, Santoro A, Barbieri R, Salzano S
and Ursini MV: Ochratoxin A and zearalenone: A comparative study on
genotoxic effects and cell death induced in bovine lymphocytes.
Mutat Res. 557:19–27. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Pfohl-Leszkowicz A and Manderville RA:
Ochratoxin A: An overview on toxicity and carcinogenicity in
animals and humans. Mol Nutr Food Res. 51:61–99. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Marin-Kuan M, Nestler S, Verguet C,
Bezençon C, Piguet D, Delatour T, Mantle P, Cavin C and Schilter B:
MAPK-ERK activation in kidney of male rats chronically fed
Ochratoxin A at a dose causing a significant incidence of renal
carcinoma. Toxicol Appl Pharmacol. 224:174–181. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Dunnick JK, Elwell MR, Huff J and Barrett
JC: Chemically induced mammary gland cancer in the National
Toxicology Program's carcinogenesis bioassay. Carcinogenesis.
16:173–179. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Bray F, Ferlay J, Devesa SS, McGlynn KA
and Møller H: Interpreting the international trends in testicular
seminoma and nonseminoma incidence. Nat Clin Pract Urol. 3:532–543.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Jennings-Gee JE, Tozlovanu M, Manderville
R, Miller MS, Pfohl-Leszkowicz A and Schwartz GG: Ochratoxin A: In
utero exposure in mice induces adducts in testicular DNA. Toxins
(Basel). 2:1428–1444. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
175
|
Schwartz GG: Hypothesis: Does Ochratoxin A
cause testicular cancer? Cancer Causes Control. 13:91–100. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Vrabcheva T, Usleber E, Dietrich R and
Märtlbauer E: Co-occurrence of Ochratoxin A and citrinin in cereals
from Bulgarian villages with a history of Balkan endemic
nephropathy. J Agric Food Chem. 48:2483–2488. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Knasmüller S, Cavin C, Chakraborty A,
Darroudi F, Majer BJ, Huber WW and Ehrlich VA: Structurally related
mycotoxins Ochratoxin A ochratoxin B, and citrinin differ in their
genotoxic activities and in their mode of action in human-derived
liver (HepG2) cells: Implications for risk assessment. Nutr Cancer.
50:190–197. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
178
|
Thust R and Kneist S: Activity of citrinin
metabolized by rat and human microsome fractions in clastogenicity
and SCE assays on Chinese hamster V79-E cells. Mutat Res.
67:321–330. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
179
|
Ostry V, Malir F and Ruprich J: Producers
and important dietary sources of Ochratoxin A and citrinin. Toxins
(Basel). 5:1574–1586. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
180
|
Bouslimi A, Bouaziz C, Ayed-Boussema I,
Hassen W and Bacha H: Individual and combined effects of Ochratoxin
A and citrinin on viability and DNA fragmentation in cultured Vero
cells and on chromosome aberrations in mice bone marrow cells.
Toxicology. 251:1–7. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
181
|
Pfeiffer E, Gross K and Metzler M:
Aneuploidogenic and clastogenic potential of the mycotoxins
citrinin and patulin. Carcinogenesis. 19:1313–1318. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
182
|
Castegnaro M, Chernozemsky IN, Hietanen E
and Bartsch H: Are mycotoxins risk factors for endemic nephropathy
and associated urothelial cancers? Arch Geschwulstforsch.
60:295–303. 1990.PubMed/NCBI
|
|
183
|
Fink-Gremmels J: Mycotoxins: Their
implications for human and animal health. Vet Q. 21:115–120. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
184
|
Gelderblom WC, Kriek NP, Marasas WF and
Thiel PG: Toxicity and carcinogenicity of the Fusarium moniliforme
metabolite, fumonisin B1, in rats. Carcinogenesis. 12:1247–1251.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
185
|
Howard PC, Eppley RM, Stack ME, Warbritton
A, Voss KA, Lorentzen RJ, Kovach RM and Bucci TJ: Fumonisin b1
carcinogenicity in a two-year feeding study using F344 rats and
B6C3F1 mice. Environ Health Perspect. 109 Suppl 2:277–282. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
186
|
Riley RT, Wang E, Schroeder JJ, Smith ER,
Plattner RD, Abbas H, Yoo HS and Merrill AH Jr.: Evidence for
disruption of sphingolipid metabolism as a contributing factor in
the toxicity and carcinogenicity of fumonisins. Nat Toxins. 4:3–15.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
187
|
Chu FS and Li GY: Simultaneous occurrence
of fumonisin B1 and other mycotoxins in moldy corn collected from
the People's Republic of China in regions with high incidences of
esophageal cancer. Appl Environ Microbiol. 60:847–852.
1994.PubMed/NCBI
|
|
188
|
Huang C, Dickman M, Henderson G and Jones
C: Repression of protein kinase C and stimulation of cyclic AMP
response elements by fumonisin, a fungal encoded toxin which is a
carcinogen. Cancer Res. 55:1655–1659. 1995.PubMed/NCBI
|
|
189
|
Dragan YP, Bidlack WR, Cohen SM,
Goldsworthy TL, Hard GC, Howard PC, Riley RT and Voss KA:
Implications of apoptosis for toxicity, carcinogenicity, and risk
assessment: Fumonisin B(1) as an example. Toxicol Sci. 61:6–17.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
190
|
Hendricks K: Fumonisins and neural tube
defects in South Texas. Epidemiology. 10:198–200. 1999.PubMed/NCBI
|
|
191
|
Chang P-K, Cary JW, Yu J, Bhatnagar D and
Cleveland TE: The Aspergillus parasiticus polyketide synthase gene
pksA, a homolog of Aspergillus nidulans wA, is required for
aflatoxin B1 biosynthesis. Mol Gen Genet. 248:270–277. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
192
|
Gaucher GM: Mycotoxins-their biosynthesis
in fungi: Patulin and related carcinogenic lactones. J Food Prot.
42:810–814. 1979. View Article : Google Scholar
|
|
193
|
Schumacher DM, Metzler M and Lehmann L:
Mutagenicity of the mycotoxin patulin in cultured Chinese hamster
V79 cells, and its modulation by intracellular glutathione. Arch
Toxicol. 79:110–121. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
194
|
Stewart SG: Carcinogenesis: A broad
critique. J Clin Pathol. 21:5341968. View Article : Google Scholar
|
|
195
|
Dickens F and Jones HE: Carcinogenic
activity of a series of reactive lactones and related substances.
Br J Cancer. 15:85–100. 1961. View Article : Google Scholar : PubMed/NCBI
|
|
196
|
Dickens F and Jones HE: The carcinogenic
action of aflatoxin after its subcutaneous injection in the rat. Br
J Cancer. 17:691–698. 1963. View Article : Google Scholar : PubMed/NCBI
|
|
197
|
Osswald H, Frank HK, Komitowski D and
Winter H: Long-term testing of patulin administered orally to
Sprague-Dawley rats and Swiss mice. Food Cosmet Toxicol.
16:243–247. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
198
|
Mahfoud R, Maresca M, Garmy N and Fantini
J: The mycotoxin patulin alters the barrier function of the
intestinal epithelium: Mechanism of action of the toxin and
protective effects of glutathione. Toxicol Appl Pharmacol.
181:209–218. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
199
|
Lee KS and Röschenthaler RJ: DNA-damaging
activity of patulin in Escherichia coli. Appl Environ Microbiol.
52:1046–1054. 1986.PubMed/NCBI
|
|
200
|
Ueno Y, Kubota K, Ito T and Nakamura Y:
Mutagenicity of carcinogenic mycotoxins in Salmonella typhimurium.
Cancer Res. 38:536–542. 1978.PubMed/NCBI
|
|
201
|
Schoental R: Trichothecenes, zearalenone,
and other carcinogenic metabolites of Fusarium and related
microfungi. Adv Cancer Res. 45:217–290. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
202
|
Ueno Y: Toxicological features of T-2
toxin and related trichothecenes. Fundam Appl Toxicol. 4:S124–S132.
1984. View Article : Google Scholar : PubMed/NCBI
|
|
203
|
Ueno Y, Yabe T, Hashimoto H, Sekijima M,
Masuda T, Kim DJ, Hasegawa R and Ito N: Enhancement of
GST-P-positive liver cell foci development by nivalenol, a
trichothecene mycotoxin. Carcinogenesis. 13:787–791. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
204
|
Lafarge-Frayssinet C, Decloitre F, Mousset
S, Martin M and Frayssinet C: Induction of DNA single-strand breaks
by T2 toxin, a trichothecene metabolite of Fusarium: Effect on
lymphoid organs and liver. Mutat Res Genet Toxicol. 88:115–123.
1981. View Article : Google Scholar
|
|
205
|
Schothorst RC and van Egmond HP: Report
from SCOOP task 3.2.10 ‘collection of occurrence data of Fusarium
toxins in food and assessment of dietary intake by the population
of EU member states’. Subtask: trichothecenes. Subtask:
Trichothecenes. Toxicol Lett. 153:133–143. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
206
|
Eriksen GS and Pettersson H: Toxicological
evaluation of trichothecenes in animal feed. Anim Feed Sci Technol.
114:205–239. 2004. View Article : Google Scholar
|
|
207
|
Pestka JJ: Deoxynivalenol: Toxicity,
mechanisms and animal health risks. Anim Feed Sci Technol.
137:283–298. 2007. View Article : Google Scholar
|
|
208
|
Yazar S and Omurtag GZ: Fumonisins,
trichothecenes and zearalenone in cereals. Int J Mol Sci.
9:2062–2090. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
209
|
Ryu J-C, Ohtsubo K, Izumiyama N, Nakamura
K, Tanaka T, Yamamura H and Ueno Y: The acute and chronic
toxicities of nivalenol in mice. Fundam Appl Toxicol. 11:38–47.
1988. View Article : Google Scholar : PubMed/NCBI
|
|
210
|
Bony S, Olivier-Loiseau L, Carcelen M and
Devaux A: Genotoxic potential associated with low levels of the
Fusarium mycotoxins nivalenol and fusarenon X in a human intestinal
cell line. Toxicol In Vitro. 21:457–465. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
211
|
Thuvander A, Wikman C and Gadhasson I: In
vitro exposure of human lymphocytes to trichothecenes: Individual
variation in sensitivity and effects of combined exposure on
lymphocyte function. Food Chem Toxicol. 37:639–648. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
212
|
Craddock VM, Hill RJ and Henderson AR:
Stimulation of DNA replication in rat esophagus and stomach by the
trichothecene mycotoxin diacetoxyscirpenol. Cancer Lett.
38:199–208. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
213
|
Wijnands LM and van Leusden FM: An
overview of adverse health effects caused by mycotoxins and
bioassays for their detection. Research for man and environment.
RIVM report 257852,004 2000. http://rivm.openrepository.com/rivm/bitstream/10029/9410/1/257852004.pdf
|
|
214
|
Bony S, Olivier-Loiseau L, Carcelen M and
Devaux A: Genotoxic potential associated with low levels of the
Fusarium mycotoxins nivalenol and fusarenon X in a human intestinal
cell line. Toxicol In Vitro. 21:457–465. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
215
|
Miura K, Aminova L and Murayama Y:
Fusarenon-X induced apoptosis in HL-60 cells depends on caspase
activation and cytochrome c release. Toxicology. 172:103–112. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
216
|
Bondy GS, McCormick SP, Beremand MN and
Pestka JJ: Murine lymphocyte proliferation impaired by substituted
neosolaniols and calonectrins - Fusarium metabolites associated
with trichothecene biosynthesis. Toxicon. 29:1107–1113. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
217
|
Carter CJ and Cannon M: Inhibition of
eukaryotic ribosomal function by the sesquiterpenoid antibiotic
fusarenon-X. Eur J Biochem. 84:103–111. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
218
|
Moss MO: Mycotoxin review-2. Fusarium.
Mycologist. 16:158–161. 2002. View Article : Google Scholar
|
|
219
|
Yazar S and Omurtag GZ: Fumonisins,
trichothecenes and zearalenone in cereals. Int J Mol Sci.
9:2062–2090. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
220
|
Marasas WF, van Rensburg SJ and Mirocha
CJ: Incidence of Fusarium species and the mycotoxins,
deoxynivalenol and zearalenone, in corn produced in esophageal
cancer areas in Transkei. J Agric Food Chem. 27:1108–1112. 1979.
View Article : Google Scholar : PubMed/NCBI
|
|
221
|
Richard JL: Some major mycotoxins and
their mycotoxicoses - An overview. Int J Food Microbiol. 119:3–10.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
222
|
Schoental R and Cavanagh JB: Mechanisms
involved in the ‘dying-back’ process - an hypothesis implicating
coenzymes. Neuropathol Appl Neurobiol. 3:145–157. 1977. View Article : Google Scholar
|
|
223
|
Schoental R and Joffe AZ: Lesions induced
in rodents by extracts from cultures of Fusarium poae and F.
sporotrichioides. J Pathol. 112:37–42. 1974. View Article : Google Scholar : PubMed/NCBI
|
|
224
|
Schoental R, Joffe AZ and Yagen B:
Irreversible depigmentation of dark mouse hair by T-2 toxin (a
metabolite of Fusarium sporotrichioides) and by calcium
pantothenate. Experientia. 34:763–764. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
225
|
Ouanes Z, Abid S, Ayed I, Anane R, Mobio
T, Creppy EE and Bacha H: Induction of micronuclei by Zearalenone
in vero monkey kidney cells and in bone marrow cells of mice:
Protective effect of Vitamin E. Mutat Res. 538:63–70. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
226
|
Schoental R: Letter: Role of
podophyllotoxin in the bedding and dietary zearalenone on incidence
of spontaneous tumors in laboratory animals. Cancer Res.
34:2419–2420. 1974.PubMed/NCBI
|
|
227
|
Pfohl-Leszkowicz A, Chekir-Ghedira L and
Bacha H: Genotoxicity of zearalenone, an estrogenic mycotoxin: DNA
adduct formation in female mouse tissues. Carcinogenesis.
16:2315–2320. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
228
|
Program NT: National Toxicology Program:
Carcinogenesis Bioassay of Zearalenone (CAS No. 17924–92-4) in
F344/N Rats and B6C3F1 Mice (Feed Study). Natl Toxicol Program Tech
Rep Ser. 235:1–155. 1982.PubMed/NCBI
|
|
229
|
Cho S-H, Lee C-H, Jang M-R, Son Y-W, Lee
S-M, Choi I-S, Kim S and Kim D: Aflatoxins contamination in spices
and processed spice products commercialized in Korea. Food Chem.
107:1283–1288. 2008. View Article : Google Scholar
|
|
230
|
Samson RA, van Reenen-Hoekstra ES and Van
Oorschot CAN: Introduction to food-borne fungiCentraalbureau voor
Schimmelcultures. Institute of the Royal Netherlands Academy of
Arts and Sciences; 1981
|
|
231
|
Jürgen R: Mycotoxins in foodstuffs. Appl
Microbiol Biotechnol. 1:183–190. 1975.
|
|
232
|
van Egmond HP, Schothorst RC and Jonker
MA: Regulations relating to mycotoxins in food: Perspectives in a
global and European context. Anal Bioanal Chem. 389:147–157. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
233
|
Binder EM: Managing the risk of mycotoxins
in modern feed production. Anim Feed Sci Technol. 133:149–166.
2007. View Article : Google Scholar
|
|
234
|
Paterson RRM and Lima N: How will climate
change affect mycotoxins in food? Food Res Int. 43:1902–1914. 2010.
View Article : Google Scholar
|
|
235
|
Beckeman M and Skjöldebrand C:
Clusters/networks promote food innovations. J Food Eng.
79:1418–1425. 2007. View Article : Google Scholar
|
|
236
|
Wansink B: Changing eating habits on the
home front: Lost lessons from World War II research. J Public
Policy Mark. 21:90–99. 2002. View Article : Google Scholar
|
|
237
|
Kabak B, Dobson AD and Var I: Strategies
to prevent mycotoxin contamination of food and animal feed: A
review. Crit Rev Food Sci Nutr. 46:593–619. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
238
|
Magan N and Aldred D: Post-harvest control
strategies: Minimizing mycotoxins in the food chain. Int J Food
Microbiol. 119:131–139. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
239
|
Bergström R, Adami H-O, Möhner M, Zatonski
W, Storm H, Ekbom A, Tretli S, Teppo L, Akre O and Hakulinen T:
Increase in testicular cancer incidence in six European countries:
A birth cohort phenomenon. J Natl Cancer Inst. 88:727–733. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
240
|
Blot WJ, Harrington JM, Toledo A, Hoover
R, Heath CW Jr and JF Jr Fraumeni: Lung cancer after employment in
shipyards during World War II. N Engl J Med. 299:620–624. 1978.
View Article : Google Scholar : PubMed/NCBI
|
|
241
|
Tretli S and Gaard M: Lifestyle changes
during adolescence and risk of breast cancer: An ecologic study of
the effect of World War II in Norway. Cancer Causes Control.
7:507–512. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
242
|
Birner P, Oberhuber G, Stani J, Reithofer
C, Samonigg H, Hausmaninger H, Kubista E, Kwasny W,
Kandioler-Eckersberger D, Gnant M, et al: Austrian Breast &
Colorectal Cancer Study Group: Evaluation of the United States Food
and Drug Administration-approved scoring and test system of HER-2
protein expression in breast cancer. Clin Cancer Res. 7:1669–1675.
2001.PubMed/NCBI
|
|
243
|
Lu SH, Hsieh LL, Luo FC and Weinstein IB:
Amplification of the EGF receptor and c-myc genes in human
esophageal cancers. Int J Cancer. 42:502–505. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
244
|
Ross JS, Slodkowska EA, Symmans WF,
Pusztai L, Ravdin PM and Hortobagyi GN: The HER-2 receptor and
breast cancer: Ten years of targeted anti-HER-2 therapy and
personalized medicine. Oncologist. 14:320–368. 2009. View Article : Google Scholar : PubMed/NCBI
|
